Perrigo Gains Pole Position In Private-Label Allegra Race
This article was originally published in The Tan Sheet
Executive Summary
Perrigo cuts to the front of the queue for launching private-label versions of OTC Allegra, acquiring from Teva the exclusive U.S. sales and distribution rights to generic equivalents of the allergy drug